FY2024 Earnings Forecast for Jushi Issued By Ventum Cap Mkts

Jushi Holdings Inc. (OTCMKTS:JUSHF) – Ventum Cap Mkts reduced their FY2024 earnings per share (EPS) estimates for Jushi in a research note issued on Monday, November 11th. Ventum Cap Mkts analyst A. Semple now expects that the company will earn ($0.27) per share for the year, down from their previous estimate of ($0.22). Ventum Cap Mkts currently has a “Hold” rating on the stock. The consensus estimate for Jushi’s current full-year earnings is ($0.19) per share. Ventum Cap Mkts also issued estimates for Jushi’s Q4 2024 earnings at ($0.05) EPS, FY2025 earnings at ($0.19) EPS and FY2026 earnings at ($0.17) EPS.

Jushi (OTCMKTS:JUSHF) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.04). The firm had revenue of $61.61 million during the quarter, compared to analyst estimates of $65.53 million. Jushi had a negative net margin of 20.93% and a negative return on equity of 5,529.11%.

Jushi Price Performance

JUSHF stock opened at $0.39 on Thursday. The firm has a market cap of $76.69 million, a PE ratio of -1.51 and a beta of -0.86. Jushi has a 12 month low of $0.22 and a 12 month high of $1.09. The firm has a 50 day simple moving average of $0.50 and a 200 day simple moving average of $0.56.

About Jushi

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.